Early life oxidative stress and long-lasting cardiovascular effects on offspring conceived by assisted reproductive technologies: a review by Yang, Huixia et al.
 International Journal of 
Molecular Sciences
Review
Early Life Oxidative Stress and Long-Lasting
Cardiovascular Effects on Offspring Conceived by
Assisted Reproductive Technologies: A Review
Huixia Yang 1 , Christina Kuhn 1,2, Thomas Kolben 1 , Zhi Ma 1, Peng Lin 1, Sven Mahner 1,
Udo Jeschke 1,2,* and Viktoria von Schönfeldt 1
1 Department of Obstetrics and Gynecology, University Hospital, LMU Munich, 81377 Munich, Germany;
huixia.yang@med.uni-muenchen.de (H.Y.); christina.kuhn@med.uni-muenchen.de (C.K.);
thomas.kolben@med.uni-muenchen.de (T.K.); zhi.ma@med.uni-muenchen.de (Z.M.);
lin.peng@med.uni-muenchen.de (P.L.); sven.mahner@med.uni-muenchen.de (S.M.);
viktoria.schoenfeldt@med.uni-muenchen.de (V.v.S.)
2 Department of Obstetrics and Gynecology, University Hospital Augsburg, 86156 Augsburg, Germany
* Correspondence: udo.jeschke@med.uni-muenchen.de; Tel.: +49-(0)821-400-165505
Received: 29 June 2020; Accepted: 20 July 2020; Published: 22 July 2020


Abstract: Assisted reproductive technology (ART) has rapidly developed and is now widely practised
worldwide. Both the characteristics of ART (handling gametes/embryos in vitro) and the infertility
backgrounds of ART parents (such as infertility diseases and unfavourable lifestyles or diets) could
cause increased oxidative stress (OS) that may exert adverse influences on gametogenesis, fertilisation,
and foetation, even causing a long-lasting influence on the offspring. For these reasons, the safety
of ART needs to be closely examined. In this review, from an ART safety standpoint, the origins of
OS are reviewed, and the long-lasting cardiovascular effects and potential mechanisms of OS on the
offspring are discussed.
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1. Introduction
The use of assisted reproductive technology (ART) began in 1978. Since then, ART has been widely
used worldwide [1]. More than eight million human babies are estimated to have been conceived
through ART [2], and the annual increase in this number is estimated to average at 9.1% per year [1].
ART is developing rapidly, and now includes techniques such as intra-uterine insemination (IUI),
in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI)), accompanied by controlled ovarian
hyperstimulation (COH), oocyte retrieval, embryo culture, and embryo transfer, with or without
pre-implantation genetic diagnosis or screening (PGD or PGS), gametes or embryos freezing and
thawing, surgical sperm retrieval (SSR), and assisted hatching [3,4].
Despite all advances, it is unavoidable that gametes or embryos are handled in vitro. Because ART
occurs at the preimplantation period when gametes or embryos are highly sensitive and experience
developmental plasticity, the environmental stimuli may alter the embryonic developmental trajectory.
According to the ’developmental origins of adult disease’ (DOHaD) hypothesis [5], environmental
exposures in early life can exert a long-lasting influence on health and lead to adult-onset chronic
non-communicable diseases (NCDs) such as hypertension [6], cardiovascular diseases (CVDs) [7], and
type 2 diabetes mellitus (T2DM) [8]. ART can be regarded as an extreme ’exposure’, despite the fact
that conclusions of ART safety studies are conflicting, the possible adverse effects have been linked to
birth defects [9], epigenetic diseases [10], dysfunction of various body systems (e.g., cardiovascular,
metabolic, and neurological systems) [11], and paediatric neoplasms (e.g., leukaemia and Hodgkin’s
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lymphoma) [12,13]. The observed long-term outcomes of ART, including cardiometabolic and
neurological NCDs, are consistent with the DOHaD model [14].
Oxidative stress (OS) is related to an excess of reactive oxygen species (ROS) and a decrease in
antioxidant enzymes. This concept was established by Helmut in 1985 [15]. Excess ROS has been
proposed to cause severe damage during embryonic development [16], especially in the cardiovascular
system, because it is one of the first functional systems to develop. In the ART area, studies on OS
have focused on infertile men and their sperm [17,18]. It is now well established that the main cause
of male infertility is OS, which can damage sperm DNA, influencing the health of the offspring [19].
Studies have also revealed that OS plays a vital role in ART outcomes. A study found that a reduction
in OS improved ART outcomes [20]. Various factors associated with ROS production in an ART setting
have been investigated, and the antioxidant strategy in an ART setting has also been explored [20,21].
Several animal models have been applied to study the effect and associated mechanisms of OS on ART
offspring [22]. Nevertheless, to the best of our knowledge, no human epidemiological studies have
looked at the effect of OS on ART offspring. On the one hand, the health outcome-related follow-up
information of ART offspring in the available databases are insufficiently detailed and are even lacking.
On the other hand, no databases have recorded the OS status in an ART setting for ART offspring.
In fact, in other medical areas, there have been countless studies on OS/ROS, most of which are
focused on the negative effects of excessive ROS/OS. Excessive ROS/OS has been implicated in over
100 diseases [23] (e.g., diabetes mellitus [24], CVDs [25], and neurodegenerative diseases [26]), also
playing an important role in the pathogenicity of ageing [27].
In this review, from the ART point of view, we describe the origins of OS, provide a timely
synthesis of the current evidence on the long-lasting cardiovascular effects of ART-associated OS,
and discuss the potential underlying mechanisms. We expect that our review will inform future
OS-associated research in the ART area as well as propose suggestions for preventing adverse health
outcomes in ART offspring.
2. Origins of OS
2.1. Paternally Derived OS
OS has been linked to a variety of male fertility complications, including leukocytospermia [28],
varicocele [29], cryptorchidism [30], spermatic cord torsion [31], male accessory gland infections
(MAGI) [32], advanced age [33], obesity [34], diabetes [35], and autoimmune disorders [33]. Infertile men
are more likely to possess excessive levels of ROS compared to fertile men [36], which has been identified
as one of the few defined aetiologies for male infertility [37]. Recently, male oxidative stress infertility
(MOSI) has been proposed to describe infertile men with OS and abnormal semen characteristics.
This term includes many patients previously classified as having male idiopathic infertility [38].
In the male genital tract, in addition to the ROS generated from sperm cells [39], other cells may
also produce ROS. Among them, leukocytes can produce ROS at levels 1000 times higher than that of
sperm at capacitation [40] and may contribute to OS [41]. Further compounding this issue, the plasma
membrane of sperm cells contains large quantities of polyunsaturated fatty acids (PUFAs), making
them particularly susceptible to elevated ROS levels during OS [42]. OS can also negatively influence
other sperm components (i.e., nucleic acids and proteins), inducing sperm DNA fragmentation (SDF)
and low sperm motility [43]. Furthermore, compared with somatic cells, there is a lack of cytoplasm
and poorer antioxidant capacity in mature spermatozoa, thereby rendering it more vulnerable to
OS [44]. Nevertheless, it is entirely possible for sperm suffering from oxidative DNA damage to
fertilise an oocyte and thus possibly exert adverse effects on the offspring [45], especially in the context
of ICSI [46]. On the other hand, lifestyle and diet factors such as cigarette smoking [47], alcohol
abuse [48], psychological stress [49], recreational and illicit drugs use [17,50], malnutrition [51], and
excessive physical activity [52]; environmental and occupational exposures such as air pollution [53],
radiation [54], heat stress [55], plasticizers (e.g., phthalates) [56], heavy metals (e.g., cadmium) [57],
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and pesticide/herbicides [33]; and special treatments such as radiation therapy and chemotherapy have
been linked with OS [58,59] (as shown in Figure 1).
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2.2. Maternally Derived OS
Compared with studies of OS and male sperm, it appears that fewer studies have focused on OS
and oocytes/oocyte-cumulus co plexes. evertheless, it cannot be assumed that this point is less
important in o genesis, fertilisati , re a cy, a roduction of healthy offspring. After all, the
earliest det rminant of life potential is t . In the female reproductive ystem, the uterine
environment, fallopian tubes, i lar fluid are the main sources g nerating ROS [60–62].
Normal levels of ROS are responsible f establishment in IVF cycles, while excess ROS in
the follicular fluid can present a substa ti l essful a sisted reproduction [63].
Recent studies have also shown that OS may cause absence of the oocyte meiotic spindle and may
be closely associated with low fertilization rates, compromised e bryonic quality, and decreased clinical
pregnancy rates [64]. In fact, women attending ART units are usually of advanced age and/or have
been diagnosed with other diseases (e.g., endometriosis [65], polycystic ovary syndrome (PCOS) [66],
hydrosalpinx [67], and obesity [52]). After pregnancy, women who underwent ART have been reported
to be affected by higher incidences of several pregnancy complications (e.g., hypertensive disorders
of pregnancy (HDP) [68], gestational diabetes mellitus (GDM) [68], intrauterine growth restriction
(IUGR) [69], and preterm birth [68]). All these diseases and pregnancy complications are associated
with increased OS, which might exert an influence on the offspring’s development [70]. Specifically,
during the maternal ageing process, significantly increased OS occurs in the ovarian and follicular
environment, causing impaired oocyte quality and compromised oocyte meiosis [71]. Similar to men,
unfavourable lifestyles and diets, adverse environmental and occupational exposures, and special
treatments can also contribute to excessive OS in women [52,70,72–78] (as shown in Figure 2). Different
from men, women exert OS on the offspring, not only through the fertilised oocytes, but also through
the uterine environment throughout the whole pregnancy.
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2.3. ART-Derived OS
ART requires in vitro manip lations of ga etes or embryos in a synthetic c lture environment.
Due to lack of a natural antioxidant system and factors driving ROS production (Figure 3), it is difficult
to maintain pro-oxidant/antioxidant balance in vitro, and the resulting increased OS may have an
adverse impact on the embryo/offspring. There are various stimuli of OS in the ART setting, including
cryopreservation [79,80], gamete or embryo manipulation [81], visible light [82], pH fluctuations [83],
temperature fluctuations [84], fluctuating oxygen tension (Pa, O2) [85], centrifugation [86], culture media
(especially those containing specific substances, e.g., Fe2+ and Cu2+) [62], and others. For example, in
the oviduct and uterus, under certain physiological conditions, gametes or embryos are exposed to
O2 concentrations of 2–8 % [87]. During in vitro manipulations, gametes and embryos have a chance
of being exposed to higher O2 concentrations (e.g., atmospheric O2 concentrations around 20–21%).
The presence of high concentrations of O2 during the incubation stage can activate a variety of cellular
oxidase enzymes. This in turn generates excessive ROS, leading to OS [88]. The excess ROS can impact
the biological processes of early embryonic development with potentially long-lasting health effects for
the offspring.
Collectively, compared with naturally conceived offspring, ART offspring appear to be more
likely to suffer from excessive OS. Meanwhile, it should be noted that most of the OS originating from
ART parents (e.g., adverse lifestyles and environmental exposures) and ART per se are preventable.
For ART-associated OS, the potential management includes oral antioxidant supplements for ART
parents [89] and modifications in ART protocols. These include antioxidant supplements to ART
culture media [20,89], antioxidant techniques in semen preparation, reduced oocyte-handling time,
and minimal exposure of zygotes to atmospheric oxygen concentrations [20]. The ART-associated
antioxidants consist of enzymatic antioxidants (e.g., superoxide dismutase, catalase, and the glutathione
system), non-enzymatic antioxidants (e.g., Vitamins E, C, and B9 (folic acid), melatonin, coenzyme
Q10, and L-carnitine) and combined antioxidants (e.g., Vitamin E + Vitamin C) [89]. Diets containing
antioxidant molecules for ART parents may also provide antioxidant benefits [90].
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3. OS-Associated Mechanisms in ART
3.1. Formation of OS
Various stress conditions may contribute to OS with increased production of ROS. ROS (e.g.,
superoxide (O2•−), hydroperoxyl (HO2•), hydroxyl (OH•), and peroxyl radicals (RO2•), and hydrogen
peroxide (H2O2) [91]) are generated from the partial reduction of O2 to O2•−, which occurs as a
result of oxygen’s preferential acceptance of one electron at the time of redox reactions [92]. ROS are
highly active molecules that are continuously generated by mitochondrial electron transport and
enzymes (e.g., nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase, xanthine oxidase,
and lipoxygenase) [93]. ROS that originate intracellularly can be released extracellularly [94], and play
vital roles in modulating the signaling pathways in response to intra- and extra-cellular stimuli [95].
Mitochondria are the pri ary source of ROS, resulting from its role in energy (i.e., ATP) production via
oxidative phosphorylation (OXPHOS) [92]. The major sites of ROS emission in the respiratory chain
are complex I and complex III [96]. During IVF, selected spermatozoa and oocytes are combined in a
petri dish with the fertilisation medium and are checked for fertilization after several hours’ incubation.
During this time, ROS can be generated from the oocyte/cumulus cell mass and the spermatozoa, due
to the cells’ own metabol sm, and the levels of ROS production can be elevated due to the lack of a
natural antioxidant defence system and various stimuli. Furthermore, during centrifugation, excess
ROS can be derived from th spermatozoa because of the abse ce of antioxidant-rich semin l plasma
and the activation of ROS produ ti n [20]. In addition, the external envir ment that su rounds
the cells in an ART setting can also induce OS. For example, even though the composition of the
commercial culture media changes over time with various suppliers, most contain s rum or serum
synthetic replacements, vit mins, albumin, and other component (e.g., heavy metal chelators or
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buffer). Therefore, the medium itself can be a trigger of OS [97]. Other environmental factors can also
contribute to OS as mentioned. In response to various environmental stimuli, cells produce certain
mediators and intermediates (mostly ROS) to propagate environmental signals to the cell nucleus,
affecting gene regulation and transcription while inducing various phenotypic responses (in the form
of inflammation and pathogenesis) [98].
3.2. Epigenetic Modifications Resulting from OS
Epigenetic modifications refer to dynamic and heritable changes in gene expression without DNA
sequence changes. These are profoundly involved in OS responses [99] and are regarded as potential
mechanisms that influence the developmental origins of CVDs later in adulthood [100]. Maximal
epigenetic reprogramming, characterized as ’dynamic’, ’extremely sensitive’, and ’plastic’, occurs
during the early stages of life, coinciding with the time that ART procedures take place [101,102].
Both animal studies and follow-up studies of ART children suggest that ART can cause epigenetic
perturbation in offspring [10,103], even at the two-cell stage of embryos [104]. It has been proposed
that OS during pregnancy may affect the intrauterine foetus and cause cardiovascular dysfunction
in later life through epigenetic modifications [105]. Based on these findings, we speculated that
ART-associated OS may also influence the offspring through an epigenetic mechanism. In general,
ROS can affect epigenetic modifications through both direct and indirect means [106]. For example,
OH• can directly lead to the transformation from 5-methylcytosine (5-mC, a form of DNA methylation)
to 5-hydroxymethylcytosine (5-hmC, an intermediate in active DNA demethylation [107]) [108],
which has been suggested to interfere with DNA methyltransferase 1 (DNMT1), preventing the
proper inheritance of methylation patterns, thereby causing indirect CpG sites demethylation [109].
ROS can also indirectly affect epigenetic modifications. For example, H2O2-induced OS can impair
histone demethylase activity, causing increased global histone methylation of histone H3 lysine 4
(H3K4), histone H3 lysine 27 (H3K27), and histone H3 lysine 9 (H3K9), while H3K4 trimethylation
(H3K4me3) appears to be affected most by OS; global acetylation levels show temporary decreases in
response to OS and return to normal levels after long-term OS. The activity of DNA demethylases
(ten-eleven-translocation (TET) proteins) can also be compromised by OS, inducing global 5-mC
increases and 5-hmC decreases [110]. These epigenetic modifications can then regulate gene expression
via changes in chromatin accessibility in response to OS [111]. Kietzmann et al. described an ROS-related
epigenetic landscape in cardiovascular systems; we direct interested readers to a detailed review [106].
Furthermore, evidence also suggests an interplay between OS and epidemic modifications [112,113].
For example, the down-regulation of SUV39H1 (a H3K9 histone methyltransferase) facilitates the
recruitment of SRC-1 (a histone acetyltransferase) and JMJD2C (also known as KDM4C, a H3K9 histone
demethylase) with reduced di/trimethylation and acetylation of H3K9 on the promoter of p66Shc
(a key driver of mitochondrial OS and vascular damage [114]), which may ultimately drive OS [115].
3.3. Nrf2-Mediated Anti-OS Signaling Pathway
The redox-sensitive transcriptional factor nuclear factor erythroid 2-related factor 2 (Nrf2, also
known as NFE2L2) is a well-characterized ’master regulator’ of antioxidant gene expression via its
activation of the Nrf2-antioxidant response element (ARE) pathway [116]. Nrf2 dysregulation
has been implicated in different aspects of CVDs [117] and multiple types of cancers (e.g.,
ovarian cancer [118], breast cancer [119], and glioblastoma [120]), while Nrf2 itself has been
identified as a promising therapeutic target for these chronic diseases resulting from its role in
providing cytoprotection against diverse stress and pathologies [121]. Recent preclinical data have
revealed that N-palmitoylethanolamine-oxazoline (PEA-OXA), an antioxidant compound, protects
against cardiovascular complication through upregulation of Nrf2 and Nrf2-target genes [122].
Other compounds (e.g., linarin (LIN) [123] and resveratrol (RES) [124]) also provide beneficial
effects in myocardial ischemia/reperfusion injury and CVDs by activating Nrf2. In utero, excessive OS
can trigger a cascade of molecular events, imperilling the health of offspring [125]. The Nrf2-mediated
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OS response is one of the most important cytoprotective mechanisms against OS as it transcribes
many antioxidative genes and ROS-scavenging proteins [126] that are not only closely associated with
embryo survival in in vitro conditions [127], foetal development in utero, and cardiometabolic health
in childhood or later life [128], but also involved in maintaining vascular homeostasis [129]. Given this
evidence, it is reasonable to assume that Nrf2-mediated antioxidant signaling pathway may also serve
as an important mechanism for OS-induced cardiovascular effects in ART offspring. Under redox
homeostasis, Nrf2 is bound to its inhibitor, Kelch-like ECH-associated protein 1 (Keap1), and is located
in the cytoplasm, where it facilitates the ubiquitin-mediated degradation of Nrf2. However, during OS,
Nrf2 is phosphorylated and released from Keap1 and is translocated and accumulated in the nucleus,
where it heterodimerizes with small musculoaponeurotic fibrosarcoma (Maf) proteins, binds to ARE,
and transcriptionally upregulates antioxidant gene expression [130]. The representative antioxidant
genes regulated by Nrf2 are summarized in Table 1.
Table 1. Antioxidant genes regulated by Nrf2.
Gene Protein Encoded Synonyms Species 1 Refs
GSH-based antioxidant genes
GCLC Glutamate-cysteine ligase catalytic subunit GCS, GLCL, GLCLC m, h [131–133]
GCLM Glutamate-cysteine ligase modifier subunit GLCLR m, h [131–134]
GGT1 Gamma-glutamyltransferase 1 CD224, D22S672,D22S732, GGT h [131]
GLRX Glutaredoxin GRX, GRX1 h [131]
GLS Glutaminase GLS1, KIAA0838 h [131]
GPX1 Glutathione peroxidase 1 - m [135,136]
GPX2 Glutathione peroxidase 2 GSHPX-GI m, h [131,137–140]
GPX4 Glutathione peroxidase 4 MCSP, PHGPx m [131]
GSR Glutathione-disulfide reductase - m, h [133,134]
GSTA1 Glutathione S-transferase alpha 1 - m [131,141–143]
GSTA2 Glutathione S-transferase alpha 2 - m [132,142,143]
GSTA3 Glutathione S-transferase alpha 3 - m [141–143]
GSTA4 Glutathione S-transferase alpha 4 - m [144]
GSTM1 Glutathione S-transferase mu 1 GST1, H-B, MU m [131,132,143,144]
GSTM2 Glutathione S-transferase mu 2 GST4 m [132,143,144]
GSTM3 Glutathione S-transferase mu 3 GST5 m, h [132,134,143,144]
GSTM4 Glutathione S-transferase mu 4 - m [144]
GSTM5 Glutathione S-transferase mu 5 - m [145]
GSTM6 Glutathione S-transferase mu 6 - m [144]
GSTP1 Glutathione S-transferase pi 1 FAEES3, GST3, GSTP m [131]
MGST1 icrosomal glutathione S-transferase 1 GST12, MGST-I m, h [131]
MGST2 Microsomal glutathione S-transferase 2 MGST-II m [143]
MGST3 Microsomal glutathione S-transferase 3 GST-III m [132,143]
SLC6A9 Solute carrier family 6 member 9 GLYT1 m [131]
SLC7A11 Solute carrier family 7 member 11 xCT m, h [131,146]
TXN-based antioxidant genes






SRXN1 Sulfiredoxin 1 C20orf139, dJ850E9.2, Npn3,SRX1, YKL086W m, h [131]
TXN Thioredoxin TRX m, h [131,132,135]
TXNRD1 Thioredoxin reductase 1 GRIM-12, Trxr1, TXNR m, h [131,135,144]
ATP-binding-based antioxidant genes
ABCB6 ATP binding cassette subfamily B member 6 EST45597, MTABC3, umat m, h [131]
ABCC1 ATP binding cassette subfamily C member 1 GS-X, MRP, MRP1 m, h [131]
ABCC2 ATP binding cassette subfamily C member 2 CMOAT, cMRP, DJS, MRP2 m, h [131,141]
ABCC3 ATP binding cassette subfamily C member 3 cMOAT2, EST90757, MLP2,MOAT-D, MRP3 m, h [131,141,148]
ABCC4 ATP binding cassette subfamily C member 4 EST170205, MOAT-B,MOATB, MRP4 m [131]
ABCC5 ATP binding cassette subfamily C member 5 EST277145, MOAT-C,MRP5, SMRP m [131]
Heme/iron metabolism-associated antioxidant genes
BLVRA Biliverdin reductase A BLVR h [131]
BLVRB Biliverdin reductase B FLR, SDR43U1 m, h [131]
FTH1 Ferritin heavy chain 1 FHC, FTH, FTHL6, PIG15,PLIF m, h [131]
FTL Ferritin light chain MGC71996, NBIA3 m, h [131]
HMOX1 Heme oxygenase 1 bK286B10, HO-1 m, h [131,133–135,140,145]
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Table 1. Cont.
Gene Protein Encoded Synonyms Species 1 Refs
UDP glucuronosyltransferase-associated antioxidant genes
UGT1A1 UDP glucuronosyltransferase family 1 member A1 GNT1, UGT1, UGT1A h [131]
UGT1A6 UDP glucuronosyltransferase family 1 member A6 GNT1, HLUGP, UGT1F m [138]
UGT2B1 UDP glucuronosyltransferase family 2 member B1 - m [141]
UGT2B5 UDP glucuronosyltransferase family 2 member B5 - m [132,143]
UGT2B7 UDP glucuronosyltransferase family 2 member B7 UGT2B9 m, h [131]
Other antioxidant genes
ADH7 Alcohol dehydrogenase 7 (class IV), mu or sigmapolypeptide ADH-4 m [131]
AKR1A1 Aldo-keto reductase family 1 member A1 ALR, DD3 h [132,143]
AKR1B1 Aldo-keto reductase family 1 member B1 ALDR1, AR m, h [131]
AKR1B8 Aldo-keto reductase family 1 member B8 - m [142,143]
AKR1C1 Aldo-keto reductase family 1 member C1 DD1, DDH, DDH1,HAKRC, MBAB h [131]
ALDH1A1 ldehyde dehydrogenase 1 family member A1 ALDH1, PUMB1, RALDH1 m [131]
ALDH3A1 Aldehyde dehydrogenase 3 family member A1 ALDH3 m, h [131]
ALDH7A1 Aldehyde dehydrogenase 7 family member A1 ATQ1, EPD, PDE m [131]
CAT Catalase - m [137,141]
CBR1 Carbonyl reductase 1 CBR, SDR21C1 h [131]
CYP1B1 Cytochrome P450 family 1 subfamily B member 1 CP1B, GLC3A m [131]
CYP2B9 Cytochrome P450 family 2 subfamily B member 9 - m [131]
G6PD Glucose-6-phosphate dehydrogenase G6PD1 m, h [131]
IDH1 Isocitrate dehydrogenase (NADP(+)) 1, cytosolic - m [131]
ME1 Malic enzyme 1 - m, h [131]
NQO1 NAD(P)H quinone dehydrogenase 1 DHQU, DIA4, DTD,NMOR1, QR1 m, h [131,132,134,135,142,143]
PGD Phosphogluconate dehydrogenase - m, h [131]
PTGR1 Prostaglandin reductase 1 LTB4DH, ZADH3 h [131]
SOD1 Superoxide dismutase 1 ALS, ALS1, IPOA m [141]
SOD2 Superoxide dismutase 2 - m [141]
SOD3 Superoxide dismutase 3 EC-SOD m [142]
TALDO1 Transaldolase 1 - m, h [131]
UGDH UDP-glucose 6-dehydrogenase - h [131]
1 The species means the gene has been identified in mouse (m) and/or human (h). Nrf2, nuclear factor erythroid
2-related factor; GSH, glutathione; UDP, uridine diphosphate. The GSH and TXN antioxidant pathways are two
important downstream pathways of Nrf2 [117].
Collectively, in the ART area, increased OS is one of the major triggers of early life genetic/epigenetic
changes in the offspring. From a preventive point of view, the adverse influence of OS can possibly
be reversed through timely appropriate interventions (e.g., medical supplements for ART children
and ART parents, chemical modification of ART culture media), opening a window for the potential
prevention of adverse long-lasting effects on ART offspring.
4. Long-Lasting Cardiovascular Effects
In the human body, ROS act as a ’double-edged sword’, playing a paradoxical role. Normal levels
of ROS are important regulators of various transcription factors and signal transduction pathways.
Excessive ROS levels can lead to OS, causing damage to cellular components (e.g., proteins, lipids, and
DNA), mitochondrial dysfunctions, inhibition of oocyte maturation, delayed embryonic development,
and induction of apoptosis in embryos [149]. Several lines of evidence suggest that OS plays a key
role in the foetal programming of adulthood CVDs [150–153]. Studies on mammalian offspring
suffering from OS (e.g., hypoxia-reoxygenation) during the gestational period reported that these
offspring developed endothelial dysfunction [150,151], enhanced myocardial contractility [151], and
hypertension [150,152] in adulthood. Foetal programming-induced alterations are transmissible not
only throughout life but also in the subsequent generation [22].
From the maternal point of view, advanced maternal age (AMA) [154,155] and OS-increased
ART-associated pregnancy complications (e.g., HDP [156,157], GDM [158], IUGR [159], and preterm
birth [100]) are frequently associated with cardiovascular dysfunction in the offspring. For example,
AMA/HDP/IUGR have been linked with increased blood pressure and/or altered cardiovascular function
in offspring [154–156,159], while GDM/preterm birth have been linked with CVDs in offspring [100,158].
Specifically, in a mouse model, it was reported that AMA affects the phenotype of the offspring in a
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sex-dependent manner: in young adulthood (four months of age), male (but not female) offspring
birthed by aged dams presented reperfusion injury and impaired endothelium-dependent relaxation.
In mature adulthood (12 months of age), female offspring showed increased systolic blood pressure,
whereas male offspring showed decreased ventricular diastolic function and increased vascular
sensitivity to methacholine [154,155].
Because of the relative novelty of ART, the follow-up times of relevant studies remain limited,
and the debate as to whether the ART techniques cause long-lasting adverse effects on the offspring
remains ongoing. Epidemiological studies on ART children and young adults revealed that the
ART offspring presented cardiovascular problems (e.g. congenital heart defect [160] and postnatal
dysfunctions of the cardiovascular system [161–164]), despite the fact that one study reported, among
22–35-year-old adults, ART did not correlate with an increase in prevalent cardiovascular risk factors.
However, the study population in this study was still in early adulthood and the authors only used
non-invasive methods to detect early markers of sub-clinical atherosclerosis; therefore, they did not
evaluate the relationships with clinical cardiovascular events (e.g., CVDs) [165]. Several systematic
reviews and meta-analyses [166–168] have been performed on the cardiovascular profiles of offspring
conceived by ART, with the results revealing mild but statistically significant cardiovascular differences
in ART offspring. As Guo et al. concluded, ART-conceived children showed mildly but statistically
significantly elevated blood pressure with sub-optimal diastolic function, thicker blood vessels, and
lower levels of low-density lipoprotein cholesterol (LDL-C) [167].
Despite the limited data on human ART offspring, subclinical cardiometabolic alterations are
detectable. Nevertheless, because CVDs are chronic, adult-onset diseases and significant signs of
CVDs require years to develop. ART is relatively new; therefore, the follow-up time of epidemiological
studies on ART remains limited (i.e., the first ’test-tube baby’, Louise Brown, was born in 1978 [169] and
was only 42 years old as of 2020). Therefore, it is too early to form a definite conclusion. More long-term
(even life-long) follow-up periods are warranted.
5. Limitations and Prospects of Current Studies
Regarding human ART studies such as those studying the influence of OS in a cohort, it is not clear
whether ART is the culprit for OS or whether the infertility factors of ART parents play confounding
roles. Moreover, the spectrum of ART-offspring demographic confounders (e.g., lifestyles, dietary
habits, familial socio-economic status, adverse childhood experiences, as well as other life experiences),
rapidly changing ART protocols, and the various types of culture media make such research more
complex. To guarantee a detailed multivariate examination of this kind of study, a large sample size
may be key to ensuring adjustments for various confounders. A comprehensive record of clinical and
laboratory parameters (independent variables) and a prospective longitudinal design are also necessary.
To independently study the influence of ART on offspring, the ART mouse is an excellent model
(i.e., there is no background of infertility; pregnancy and juvenile periods are short; and it is possible to
appropriately replicate complications in humans [168]). Human embryonic stem cells (hESC) can also
serve as a novel in vitro model to study the effects of OS on the early embryo [170].
In fact, in human assisted reproduction, both the ART procedure and the infertility backgrounds
of ART parents may cause increased OS. Increased OS not only is the reason for patients visiting
ART clinics, but it is also the outcome of in vitro ART manipulations. Despite increased OS being a
prevalent phenomenon in ART, (i) there are no established uniform indicators of OS or standardized
cut-off values for ART, ART men, and ART women; (ii) some ART laboratories make no attempt to test
for the presence of OS; (iii) neither do the majority of ART clinics analyse their patients’ OS statuses
nor pay attention to the clinical causes and sentinel signs of OS, nor do they suggest any changes to
OS-related adverse lifestyles or instigate any measures to maintain the redox balance in their patients.
Nevertheless, these approaches will not only increase a couple’s chances of natural conception, but
will also optimise the efficiency of the ART and the health of ART offspring.
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6. Conclusions
OS, which have potentially adverse effects on ART offspring, may derive not only from ART per
se but also from the infertility backgrounds of ART parents. OS might exert a long-lasting influences
on the offspring’s cardiovascular system via epigenetic and genetic alterations (Figure 4).
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Abbreviations
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IUI Intra-uterine insemination
IVF In vitro fertilisation
ICSI Intracytoplasmic sperm injection
COH Controlled ovarian hyperstimulation
PGD Pre-implantation genetic diagnosis
PGS Pre-implantation genetic screening
SSR Surgical sperm retrieval
DOHaD Developmental Origins of Adult Disease
NCDs Non-communicable diseases
CVDs Cardiovascular diseases
T2DM Type 2 diabetes mellitus
OS Oxidative stress
ROS Reactive oxygen species
MAGI Male accessory gland infections
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MOSI Male oxidative stress infertility
PUFAs Polyunsaturated fatty acids
SDF Sperm DNA fragmentation
PCOS Polycystic ovary syndrome
HDP Hypertensive disorders of pregnancy
GDM Gestational diabetes mellitus











DNMT1 DNA methyltransferase 1
H3K4 Histone H3 lysine 4
H3K27 Histone H3 lysine 27
H3K9 Histone H3 lysine 9
H3K4me3 H3K4 trimethylation
TET Ten-eleven-translocation
Nrf2 Nuclear factor erythroid 2-related factor




Keap1 Kelch-like ECH-associated protein 1
Maf Musculoaponeurotic fibrosarcoma
AMA Advanced maternal age
LDL-C Low-density lipoprotein cholesterol
hESC Human embryonic stem cells
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